Skip to main content

Table 4 Characteristics, risk factors, and diagnostic and therapeutic procedures for aortic aneurysm and dissection admissions in type 2 diabetes mellitus (T2DM) versus non-diabetic patients, according to year of study (2002, 2006, 2010, and 2014)

From: Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002–2014)

 

2002

2006

2010

2014

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

T2DM

No T2DM

p value

N (%)a,b

390 (100)

390 (100)

NA

615 (100)

615 (100)

NA

753 (100)

753 (100)

NA

841 (100)

841 (100)

NA

Age adjusted rate per 100.000 inhabitants

2.03

NA

NA

2.93

NA

NA

3.3

NA

NA

3.45

NA

NA

Male sex, n (%)

364 (93.33)

364 (93.33)

NA

591 (96.1)

591 (96.1)

NA

710 (94.29)

710 (94.29)

NA

802 (95.36)

802 (95.36)

NA

Age, mean (SD)a,b

69.84 (9.03)

69.84 (9.03)

NA

71.06 (8.12)

71.06 (8.12)

NA

71.43 (8.08)

71.43 (8.08)

NA

72.41 (7.85)

72.41 (7.85)

NA

40–59 years, n (%)

56 (14.36)

56 (14.36)

NA

60 (9.76)

60 (9.76)

NA

55 (7.3)

55 (7.3)

NA

51 (6.06)

51 (6.06)

NA

60–69 years, n (%)

106 (27.18)

106 (27.18)

177 (28.78)

177 (28.78)

234 (31.08)

234 (31.08)

247 (29.37)

247 (29.37)

70–79 years, n (%)

184 (47.18)

184 (47.18)

288 (46.83)

288 (46.83)

350 (46.48)

350 (46.48)

376 (44.71)

376 (44.71)

≥ 80 years, n (%)

44 (11.28)

44 (11.28)

90 (14.63)

90 (14.63)

114 (15.14)

114 (15.14)

167 (19.86)

167 (19.86)

CCI, mean (SD)a,b

2.48 (0.82)

1.42 (0.82)

< 0.01

2.56 (0.84)

1.49 (0.79)

< 0.01

2.59 (0.76)

1.53 (0.79)

< 0.01

2.7 (0.84)

1.59 (0.75)

< 0.01

Smoking, n (%)a,b

139 (35.64)

136 (34.87)

0.802

238 (38.7)

214 (34.8)

0.145

323 (42.9)

316 (41.97)

0.702

363 (43.16)

360 (42.81)

0.879

Obesity, n (%)a,b

19 (4.87)

11 (2.82)

0.149

32 (5.2)

20 (3.25)

0.099

79 (10.49)

28 (3.72)

< 0.01

82 (9.75)

45 (5.35)

0.001

Hypertension, n (%)a,b

213 (54.62)

139 (35.64)

< 0.01

367 (59.67)

269 (43.74)

< 0.01

470 (62.42)

371 (49.27)

< 0.01

541 (64.33)

430 (51.13)

< 0.01

Lipid metabolism disorders, n (%)a,b

47 (12.05)

20 (5.13)

0.001

129 (20.98)

83 (13.5)

0.001

292 (38.78)

200 (26.56)

< 0.01

427 (50.77)

292 (34.72)

< 0.01

Renal diseases, n (%)a,b

31 (7.95)

28 (7.18)

0.686

67 (10.89)

62 (10.08)

0.635

114 (15.14)

84 (11.16)

0.021

147 (17.48)

118 (14.03)

0.053

Atrial fibrillation, n (%)a,b

38 (9.74)

26 (6.67)

0.112

58 (9.43)

67 (10.89)

0.376

90 (11.95)

106 (14.08)

0.212

157 (18.67)

116 (13.79)

0.007

CHF, n (%)

22 (5.64)

13 (3.33)

0.100

29 (4.72)

24 (3.9)

0.493

44 (5.84)

40 (5.31)

0.638

41 (4.88)

34 (4.04)

0.407

Mechanical ventilation, n (%)

36 (9.23)

32 (8.21)

0.593

55 (8.94)

48 (7.8)

0.483

36 (4.78)

60 (7.97)

0.009

61 (7.25)

62 (7.37)

0.919

HD/DP, n (%)

7 (1.79)

5 (1.28)

0.566

18 (2.93)

14 (2.28)

0.467

16 (2.12)

23 (3.05)

0.240

25 (2.97)

24 (2.85)

0.884

Thoracic aorta aneurysm open surgery, n (%)a,b

9 (2.31)

9 (2.31)

0.903

22 (3.58)

30 (4.88)

0.198

25 (3.32)

46 (6.11)

0.005

43 (5.11)

50 (5.95)

0.379

TEVAR, n (%)

0 (0)

0 (0)

NA

0 (0)

0 (0)

NA

25 (3.32)

16 (2.12)

0.133

37 (4.4)

32 (3.8)

0.508

Abdominal aorta aneurysm open surgery, n (%)a,b

86 (22.05)

94 (24.1)

0.454

111 (18.05)

112 (18.21)

0.940

100 (13.28)

128 (17)

0.038

137 (16.29)

153 (18.19)

0.281

EVAR, n (%)a,b

19 (4.87)

22 (5.64)

0.640

93 (15.12)

76 (12.36)

0.139

232 (30.81)

190 (25.23)

0.013

312 (37.1)

291 (34.6)

0.250

LHS, mean (SD)a,b

15.63 (16.07)

12.88 (12.95)

0.008

11.82 (12.11)

11.44 (16.71)

0.644

11.28 (18.3)

10.92 (13.32)

0.669

9.43 (13.33)

9.63 (13.24)

0.760

In-hospital mortality, n (%)a

56 (14.36)

50 (12.82)

0.447

77 (12.52)

78 (12.68)

0.920

82 (10.89)

90 (11.95)

0.446

68 (8.09)

84 (9.99)

0.118

  1. CCI charlson comorbidity index, CHF congestive heart failure, HD/DP hemodyalisis/peritoneal dialysis, TEVAR endovascular implantation of graft in thoracic aorta, EVAR endovascular implantation of graft in abdominal aorta, LHS length of hospital stay
  2. aSignificant time trend among T2DM sufferers
  3. bSignificant time trend among non-T2DM sufferers